Optimizing the channel strategy to expand patient access to cell and gene therapies
Product innovation brings new treatment hope to patients in need, including potentially transformative cell and gene therapies for rare diseases. To successfully bring these life-changing or life-saving therapies to patients, companies will need to develop a well-planned channel strategy.
Stay informed about US Health Policy News
Health Policy Weekly
Health Policy weekly recaps legislative and regulatory developments and healthcare reform news that impacts the healthcare industry, particularly pharmaceutical, biotech, and device manufacturers, providers, and managed care.
Developed by a multi-disciplinary editorial board that includes health policy and reimbursement strategy experts, Health Policy Weekly delivers key insights to your inbox every week.
Developed by a multi-disciplinary editorial board that includes health policy and reimbursement strategy experts, Health Policy Weekly delivers key insights to your inbox every week.
Keep up on key global health technology assessment news
HTA Quarterly
Each edition of HTA Quarterly provides insights and analysis from global experts with local market expertise on key priorities and perspectives affecting HTA.
From therapeutic area spotlights to geographic reviews to critical industry topics, keep current on HTA activity around the globe with HTA Quarterly.
Webinar
Best Practices for Building a Channel Strategy: Lessons Learned and Forward-Thinking Initiatives to Maximize Market Reach